Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...
Lazard notes that this morning, Pfizer (PFE) announced that its applications for maraviroc would receive accelerated review in the U.S. and Europe. The FDA priority review process takes approx six ...
When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a conditional payment tied to the timely FDA approval of atrasentan without a ...
CEO Robert Blum emphasized the company's progress toward the potential commercialization of aficamten, noting the FDA's extension of the PDUFA date to December 26, 2025, to review a submitted REMS ...